Abstract
The integrin linked kinase (ILK) is a cytoplasmic effector of integrin receptors, involved in the regulation of integrin binding properties as well as the activation of cell survival and proliferative pathways, including those involving MAP kinase, PKB/Akt and GSK-3β. Overexpression of ILK in cultured intestinal and mammary epithelial cells has been previously shown to induce changes characteristic of oncogenic transformation, including anchorage-independent growth, invasiveness, suppression of anoikis and tumorigenicity in nude mice. In order to determine if ILK overexpression can result in the formation of mammary tumors in vivo, we generated transgenic mice expressing ILK in the mammary epithelium, under the transcriptional control of the mouse mammary tumor virus (MMTV) long terminal repeat (LTR). By the age of 6 months, female MMTV/ILK mice developed a hyperplastic mammary phenotype, which was accompanied by the constitutive phosphorylation of PKB/Akt, GSK-3β and MAP kinase. Focal mammary tumors subsequently appeared in 34% of the animals at an average age of 18 months. Given the focal nature and long latency of the tumors, however, additional genetic events are likely required for tumor induction in the MMTV/ILK mice. These results provide the first direct demonstration of a potential oncogenic role for ILK, which is upregulated in human tumors and tumor cell lines.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Attwell S, Roskelley C, Dedhar S . 2000 Oncogene 19: 3811–3815
Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ . 1979 Biochemistry 18: 5294–5299
Chung DH, Lee JI, Kook MC, Kim JR, Kim SH, Choi EY, Park SH, Song HG . 1998 Vir. Arch. 433: 113–117
Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA . 1995 Nature 378: 785–789
Dedhar S . 2000 Curr. Opin. Cell Biol. 12: 250–256
Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S . 1998 Proc. Natl. Acad. Sci. USA 95: 11211–11216
Deng JT, Van Lierop JE, Sutherland C, Walsh MP . 2001 J. Biol. Chem. 276: 16365–16373
Giancotti FG, Ruoslahti E . 1999 Science 285: 1028–1032
Graff JF, Deddens JA, Konicek BW, Colligan BM, Hurst BM, Carter HW, Carter JH . 2001 Clin. Cancer Res. 7: 1987–1991
Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J, Bell JC, Dedhar S . 1996 Nature 379: 91–96
Huang Y, Li J, Zhang Y, Wu C . 2000 J. Cell Biol. 150: 861–871
Hutchinson J, Jin J, Cardiff RD, Woodgett JR, Muller WJ . 2001 Mol. Cell. Biol. 21: 2203–2212
Janji B, Melchior C, Gouon V, Vallar L, Kieffer N . 1999 Int. J. Cancer 83: 255–262
Janji B, Melchior C, Gouon V, Vallar L, Kieffer N . 2000 Oncogene 19: 3069–3077
Landesman-Bollag E, Romieu-Mourez R, Song DH, Sonenshein GE, Cardiff RD, Seldin DC . 2001 Oncogene 20: 3247–3257
Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P . 1988 Cell 54: 105–115
Novak A, Hsu S-C, Leung-Hagesteijn C, Raddeva G, Papkoff J, Montesano R, Roskelley C, Grosschedl R, Dedhar S . 1998 Proc. Natl. Acad. Sci. USA 95: 4374–4379
Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, Sanghera J, Dedhar S . 2000 Proc. Natl. Acad. Sci. USA 97: 3207–3212
Persad S, Attwell S, Gray V, Mawji N, Deng JT, Leung D, Yan J, Sanghera J, Walsh MP, Dedhar S . 2001a J. Biol. Chem. 276: 27462–27469
Persad S, Troussard A, McPhee TR, Mulholland D, Dedhar S . 2001b J. Cell Biol. 153: 1161–1174
Radeva G, Petrocelli T, Behrend E, Leung-Hagesteijn C, Filmus J, Slingerland J, Dedhar S . 1997 J. Biol. Chem. 272: 13937–13944
Schmeichel KL, Weaver VM, Bissell MJ . 1998 J. Mammary Gland Biol. Neoplasia 3: 201–213
Seger D, Seger R, Shaltiel S . 2001 J. Biol. Chem. 276: 16998–17006
Shaw LM . 1999 J. Mammary Gland Biol. Neoplasia 4: 367–376
Sinn E, Muller W, Pattengale P, Tepler I, Wallace R, Leder P . 1987 Cell 49: 465–475
Somasiri A, Howarth A, Goswami D, Dedhar S, Roskelley CD . 2001 J. Cell Sci. 114: 1125–1136
Song DH, Sussman J, Seldin DC . 2000 J. Biol. Chem. 275: 23790–23797
Sternlicht MD, Bissell MJ, Werb Z . 2000 Oncogene 19: 1102–1113
Streuli CH, Edwards GM . 1998 J. Mammary Gland Biol. Neoplasia 3: 151–163
Troussard AA, Tan C, Yoganathan N, Dedhar S . 1999 Mol. Cell. Biol. 19: 7420–7427
Troussard AA, Costello P, Yoganathan TN, Kumagai S, Roskelley CD, Dedhar S . 2000 Oncogene 19: 5444–5452
Tu Y, Li F, Goicoechea S, Wu C . 1999 Mol. Cell. Biol. 19: 2425–2434
Webster MA, Hutchinson JN, Rauh MJ, Muthuswamy SK, Anton M, Tortorice CG, Cardiff RD, Graham FL, Hassell JA, Muller WJ . 1998 Mol. Cell. Biol. 18: 2344–2359
Wu C, Keightley SY, Leung-Hagesteijn C, Radeva G, Coppolino M, Boicoechea S, McDonald JA, Dedhar S . 1998 J. Biol. Chem. 273: 528–536
Yoganathan TN, Costello P, Chen X, Jabali M, Yan J, Leung D, Zhang Z, Yee A, Dedhar S, Sanghera J . 2000 Biochem. Pharmacol. 60: 1115–1119
Zervas CG, Gregory SL, Brown NH . 2001 J. Cell Biol. 152: 1007–1018
Zutter MM, Sun H, Santoro SA . 1998 J. Mammary Gland Biol. Neoplasia 3: 191–200
Acknowledgements
The authors would like to thank Judy E Walls (UC Davis School of Medicine) for excellent technical work on the immunohistochemistry, and Monica Graham (McMaster University) for genotyping the ILK strains. This work was supported by the US Department of Defense Breast Cancer Research Initiative DAMD 17-99-1-9284 (D White) and DAMD 17-99-1-9286 (WJ Muller), by grants from the National Cancer Institute of Canada (S Dedhar), and by grant 5JB-0014 from the State of California Breast Cancer Research Program (RD Cardiff).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
White, D., Cardiff, R., Dedhar, S. et al. Mammary epithelial-specific expression of the integrin linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice. Oncogene 20, 7064–7072 (2001). https://doi.org/10.1038/sj.onc.1204910
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204910
Keywords
This article is cited by
-
Anoikis resistance––protagonists of breast cancer cells survive and metastasize after ECM detachment
Cell Communication and Signaling (2023)
-
Overexpression of integrin-linked kinase (ILK) is associated with tumor progression and an unfavorable prognosis in patients with colorectal cancer
Journal of Molecular Histology (2013)
-
MicroRNA-mediated upregulation of integrin-linked kinase promotes Src-induced tumor progression
Oncogene (2012)
-
Inhibition of high glucose-induced VEGF and ICAM-1 expression in human retinal pigment epithelium cells by targeting ILK with small interference RNA
Molecular Biology Reports (2012)
-
Integrin-linked kinase: Not so ‘pseudo’ after all
Oncogene (2011)